Silver Book Fact

Between 2.7 and 6.1 million Americans have AFib.

The Value of MedTech: to treat AFib. Washington, D.C.: AdvaMed; 2015:1. http://www.lifechanginginnovation.org/sites/default/files/files/AFib-factsheet_FINAL.pdf. Accessed November 9, 2015

Reference

Title
The Value of MedTech: to treat AFib
Publisher
AdvaMed
Publication Date
2015
Pages
1
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.        
  • Age as a risk factor of Afib
    At age 60, 1 in 25 Americans have AFib. At age 80+, this increases to nearly 1 in 10.  
  • Annual AFib-related stroke Medicare costs
    Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional…  
  • AFib increases mortality risk
    Most importantly, AFib double the person’s risk of death and is the cause of nearly 100,000 deaths in the U.S. each year.  
  • AFib prevalence rate projection, 2050
    By 2050, it is estimated that 88% of Americans with atrial fibrillation will be age 65 and older.